Document is current
Any future updates will be listed below
-
Authors
Dubey, Shirish https://orcid.org/0000-0002-9979-6066
Adebajo, Adewale O. https://orcid.org/0000-0001-7368-7083
Bosworth, Ailsa https://orcid.org/0000-0001-7634-414X
Stones, Simon R. https://orcid.org/0000-0002-5943-1310
Ellis, Spencer https://orcid.org/0000-0002-4642-1906
- License Information
-
More Information
Article History
Received: 2 December 2025
Revised: 17 February 2026
Accepted: 18 February 2026
First Online: 28 February 2026
Compliance with ethical standards
:
: No conflicts for any authors relating to this article.
: SD: Advisory boards for AbbVie and Boehringer Ingelheim. AO A: No relevant disclosures. AB: No relevant disclosures relating to this article. SRS : Employment : Amica Scientific, a medical communications and patient engagement company that is funded by pharmaceutical companies, previously Envision Pharma Group; Honoraria : European Alliance of Associations for Rheumatology (EULAR), Kennedy Trust, National Institute for Health and Care Research (NIHR), Sage, Taylor & Francis, University of British Columbia, and University of Leeds; Board Directorship : RAiISE, a charitable incorporated organisation registered in England and Wales Number 1180704; Committee Membership : International Society for Medical Publication Professionals (ISMPP) Patient Engagement Task Force, EULAR People with Arthritis/Rheumatism in Europe (PARE) Committee, EULAR Congress Committee, EULAR Council, PxP 2025 Organising Committee; Other : Guest Editor for the BMC journal Research Involvement and Engagement . SE: Trustee British Society for Rheumatology.
Free to read: This content has been made available to all.
